Brian Nowosielski

4 days ago | drugtopics.com | Brian Nowosielski |Larry King

With the help of well-established pharmacy interoperability with other health care entities, pharmacists are able to utilize data more sufficiently, connect with patients and other providers more easily, and standout amongst other health care professionals. Larry King, PharmD, Director of Product Safety & Performance at Surescripts, hosted a session at the National Council for Prescription Drug Programs (NCPDP) 2025 Annual Conference, held May 5 to May 7 in Scottsdale, Arizona.

4 days ago | drugtopics.com | Brian Nowosielski

President Donald Trump signed an executive order Monday forcing drug manufacturers to lower their costs and make drug prices similar to the country with the lowest costs in the world, according to a White House news release.1 Serving as a wide-reaching provision that will impact millions of patients and providers around the world, President Trump claims that the order will slash drug prices in the US by 30%-80%.2 “I will be signing one of the most consequential Executive Orders in our...

6 days ago | drugtopics.com | Brian Nowosielski |Vin Gupta

Pharmacists are significantly rooted in their respective communities more so than most other providers, making them the health care professionals best-positioned to address social determinants of health (SDOH). “Pharmacists are about as embedded a clinician in somebody’s community as anybody, more so probably than physicians, than nurses. They are truly the front line,” said Vin Gupta, MD, former Chief Medical Officer at Amazon Pharmacy and renowned US medical analyst.

1 week ago | drugtopics.com | Brian Nowosielski |Stanley Campbell |Yi Deng

As artificial intelligence (AI) within health care is developed further, pharmacies are increasingly reaping its benefits and are now using AI data to stay compliant with federal and state government regulations. “With AI, we're actually doing about 3 and a half billion calculations in about 50 milliseconds and giving a response into the [pharmacist’s] workflow,” said Stanley V. Campbell, Jr, CEO of EagleForce Associates.

1 week ago | drugtopics.com | Brian Nowosielski |Antonio Ciaccia

Federal investigations, pharmacy community advocacy, and bipartisan support for reform are all just a few things that have contributed to the uncovering of the country’s largest prescription middlemen, or pharmacy benefit managers (PBMs) as people now know them. While they have become scrutinized for their role in the pharmaceutical supply chain, PBMs were once designed to save patients money and keep pharmacies afloat with reimbursable prescription benefits.